(Q35788120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

The potential of positron-emission tomography to study anticancer-drug resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Terry Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pat Price

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

457-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

Clinical role of positron emission tomography in oncology

29 December 2019

cites work

1 reference

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

21 January 2018

1 reference

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.

21 January 2018

1 reference

Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.

21 January 2018

1 reference

PET imaging of gene expression

21 January 2018

1 reference

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

21 January 2018

1 reference

PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer

21 January 2018

1 reference

Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin

21 January 2018

1 reference

Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.

21 January 2018

1 reference

Clinical measurement of blood flow in tumours using positron emission tomography: a review

21 January 2018

1 reference

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate

21 January 2018

1 reference

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

21 January 2018

1 reference

Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases

21 January 2018

1 reference

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases

21 January 2018

1 reference

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

21 January 2018

1 reference

Endostatin imaging to help understanding of antiangiogenic drugs.

21 January 2018

1 reference

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

21 January 2018

1 reference

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis

21 January 2018

1 reference

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates

21 January 2018

1 reference

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

21 January 2018

1 reference

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance

21 January 2018

1 reference

Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing

21 January 2018

1 reference

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

21 January 2018

1 reference

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report

21 January 2018

1 reference

18FFluoroazomycinarabinofuranoside (18FAZA) and 18FFluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors

21 January 2018

1 reference

Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer

21 January 2018

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker

21 January 2018

1 reference

Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results

21 January 2018

1 reference

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET.

21 January 2018

1 reference

Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET.

21 January 2018

1 reference

Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography

21 January 2018

1 reference

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

21 January 2018

1 reference

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

21 January 2018

1 reference

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

21 January 2018

1 reference

Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride

21 January 2018

1 reference

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

21 January 2018

1 reference

Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo

21 January 2018

1 reference

Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway

21 January 2018

1 reference

Synthesis and preliminary biological evaluation of 6-O-[11C]-[(methoxymethyl)benzyl]guanines, new potential PET breast cancer imaging agents for the DNA repair protein AGT.

21 January 2018

1 reference

Synthesis and preliminary biological evaluation of radiolabeled O6-benzylguanine derivatives, new potential PET imaging agents for the DNA repair protein O6-alkylguanine-DNA alkyltransferase in breast cancer

21 January 2018

1 reference

Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.

21 January 2018

1 reference

Biodistribution of 3,4-dihydro-5-[11C]methoxy-1(2H)-isoquinolinone, a potential PET tracer for poly(ADP-ribose) synthetase.

21 January 2018

1 reference

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

18F-radiopharmacokinetics of [18F]-5-fluorouracil in a mouse bearing two colon tumors with a different 5-fluorouracil sensitivity: a study for a correlation with oncological results

21 January 2018

1 reference

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.

21 January 2018

1 reference

Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy

21 January 2018

1 reference

Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil

21 January 2018

1 reference

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?

21 January 2018

1 reference

2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.

21 January 2018

1 reference

Comparison of simplified quantitative analyses of FDG uptake

21 January 2018

1 reference

In vivo molecular-genetic imaging

21 January 2018

1 reference

PET as a potential tool for imaging molecular mechanisms of oncology in man.

21 January 2018

1 reference

PET for in vivo pharmacokinetic and pharmacodynamic measurements

21 January 2018

1 reference

(18)F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET

21 January 2018

1 reference

21 January 2018

1 reference

Monitoring gene therapy with reporter gene imaging

21 January 2018

1 reference

Imaging methods in gene therapy of cancer

31 March 2020

1 reference

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography

31 March 2020

1 reference

31 March 2020

1 reference

Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

31 March 2020

1 reference

Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography

31 March 2020

1 reference

Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes

31 March 2020

1 reference

Tumoral drug metabolism: perspectives and therapeutic implications

31 March 2020

1 reference

Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumours using 15O and positron emission tomography: analytical techniques and preliminary results.

31 March 2020

1 reference

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

31 March 2020

1 reference

Syntheses of the First Endothelin-A- and -B-Selective Radioligands for Positron Emission Tomography

31 March 2020

1 reference

Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ

31 March 2020

1 reference

Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines

31 March 2020

1 reference

Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose

31 March 2020

1 reference

Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole.

31 March 2020

1 reference

Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5

31 March 2020

1 reference

Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine

31 March 2020

1 reference

18F-labelled annexin V: a PET tracer for apoptosis imaging

31 March 2020

1 reference

Molecular-genetic imaging: current and future perspectives

31 March 2020

1 reference

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

31 March 2020

1 reference

Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study

31 March 2020

1 reference

18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil

31 March 2020

1 reference

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa

31 March 2020

1 reference

Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group

31 March 2020

1 reference

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action

31 March 2020

1 reference

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170448%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference